# Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

> **NCT00618722** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kythera Biopharmaceuticals** · enrollment: 85 (actual)

## Conditions studied

- Moderate or Severe Submental Fullness

## Interventions

- **DRUG:** Deoxycholic Acid Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00618722
- **Lead sponsor:** Kythera Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2015-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618722, "Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00618722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*